| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Recent advancements in precision medicine, particularly through innovative applications of circulating tumor DNA (ctDNA) technology and developments in transplantation methods, reflect a strong focus on enhancing patient care. Natera is significantly contributing to this field, as evidenced by their involvement in clinical trials and the successful testing of personalized treatments for various cancers. These advances are paving the way for more effective monitoring and management of diseases, particularly in oncology and transplantation. Ongoing product development efforts showcase Natera's commitment to precision medicine and its potential to improve clinical outcomes. |
| The price action of Natera (NTRA) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 1 is bullish. The market sentiment at 0.8 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.NTRA is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1, and the negative at -0.2 on 2025-05-08. The forces of Sentiment towards Fundamentals (3.7), Market Risk Appetite (1), Sector Price Trend (1), Stock Price Trend (1), Option Sentiment (0), and Price Level Sentiment (0) will drive up the price. The forces of and Valuation Sentiment (-1) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| NTRA | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-08 | 0%(0%) | 1 | 0.25% | 0.9 | 3.7 | -1 | |||||||
| 2025-05-07 | 0%(0%) | 1 | 0.25% | 1 | 4.2 | -1 | |||||||
| 2025-05-06 | 0%(0%) | 1 | 0.25% | 1.1 | 4.9 | -1 | |||||||
| 2025-05-05 | 0%(0%) | 1 | 0.25% | 1 | 4.6 | -1 | |||||||
| 2025-05-04 | 0%(0%) | 1 | 0.25% | 1 | 4.2 | -1 | |||||||
| 2025-05-03 | 0%(0%) | 1 | 0.25% | 1 | 4.2 | -1 | |||||||
| 2025-05-02 | 0%(0%) | 1 | 0.25% | 1 | 4.2 | -1 | |||||||
| 2025-05-01 | 0%(0%) | 1 | 0.25% | 1 | 4.2 | -1 | |||||||
| 2025-04-30 | 0%(0%) | 1 | 0.25% | 1 | 4.2 | -1 | |||||||
| 2025-04-29 | 0%(0%) | 1 | 0.25% | 1 | 4.2 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-09-29 22:57:03 Collaboration with partners to share data from clinical trials indicates strategic alliances that could enhance Natera's position in the industry. |
| 2025-09-29 22:57:03 The response from the market to Natera's earnings metrics suggests investor optimism based on performance against expectations. |
| 2025-09-29 22:57:03 Natera's involvement in presenting new datasets from significant clinical trials indicates ongoing product development and innovative contributions to the field of precision medicine. |
| 2025-09-29 22:57:03 Natera reports a loss but surpasses revenue estimates, which shows a positive aspect in their earnings despite the loss. |
| 2025-09-29 22:57:03 The articles focus on Natera's earnings reports, highlighting the comparison between actual performance and market estimates, indicating a mixed but generally positive outlook. |